A detailed history of Charles Schwab Investment Management Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 448,184 shares of WST stock, worth $148 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
448,184
Previous 441,428 1.53%
Holding current value
$148 Million
Previous $145 Million 7.48%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$277.16 - $333.3 $1.87 Million - $2.25 Million
6,756 Added 1.53%
448,184 $135 Million
Q2 2024

Aug 12, 2024

BUY
$314.68 - $395.94 $2.03 Million - $2.56 Million
6,464 Added 1.49%
441,428 $145 Million
Q1 2024

May 08, 2024

BUY
$338.27 - $413.0 $4.11 Million - $5.02 Million
12,146 Added 2.87%
434,964 $172 Million
Q4 2023

Feb 06, 2024

BUY
$318.29 - $392.21 $2.58 Million - $3.17 Million
8,094 Added 1.95%
422,818 $149 Million
Q3 2023

Nov 08, 2023

BUY
$354.9 - $412.41 $1.44 Million - $1.68 Million
4,069 Added 0.99%
414,724 $156 Million
Q2 2023

Aug 09, 2023

BUY
$334.63 - $382.47 $1.69 Million - $1.93 Million
5,037 Added 1.24%
410,655 $157 Million
Q1 2023

May 11, 2023

SELL
$232.5 - $346.47 $9.91 Million - $14.8 Million
-42,645 Reduced 9.51%
405,618 $141 Million
Q4 2022

Feb 13, 2023

BUY
$209.34 - $261.61 $4.69 Million - $5.86 Million
22,392 Added 5.26%
448,263 $105 Million
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $2.96 Million - $4.13 Million
12,024 Added 2.91%
425,871 $105 Million
Q2 2022

Aug 15, 2022

BUY
$280.61 - $420.45 $3.34 Million - $5 Million
11,896 Added 2.96%
413,847 $125 Million
Q1 2022

May 13, 2022

BUY
$357.49 - $445.92 $695,318 - $867,314
1,945 Added 0.49%
401,951 $165 Million
Q4 2021

Feb 11, 2022

BUY
$402.25 - $471.34 $6.25 Million - $7.33 Million
15,549 Added 4.04%
400,006 $188 Million
Q3 2021

Nov 16, 2021

SELL
$363.01 - $468.47 $120,882 - $156,000
-333 Reduced 0.09%
384,457 $163 Million
Q2 2021

Aug 16, 2021

SELL
$284.77 - $363.2 $812,448 - $1.04 Million
-2,853 Reduced 0.74%
384,790 $138 Million
Q1 2021

May 17, 2021

SELL
$257.29 - $307.53 $323,413 - $386,565
-1,257 Reduced 0.32%
387,643 $109 Million
Q4 2020

Feb 16, 2021

SELL
$261.16 - $301.66 $11.4 Million - $13.1 Million
-43,529 Reduced 10.07%
388,900 $110 Million
Q3 2020

Nov 13, 2020

SELL
$224.99 - $288.02 $37.1 Million - $47.5 Million
-165,089 Reduced 27.63%
432,429 $119 Million
Q2 2020

Aug 14, 2020

BUY
$149.8 - $227.17 $22.4 Million - $33.9 Million
149,418 Added 33.34%
597,518 $136 Million
Q1 2020

May 15, 2020

BUY
$128.96 - $174.76 $2.41 Million - $3.27 Million
18,716 Added 4.36%
448,100 $68.2 Million
Q4 2019

Feb 07, 2020

BUY
$137.6 - $151.21 $1.9 Million - $2.09 Million
13,795 Added 3.32%
429,384 $64.6 Million
Q3 2019

Nov 08, 2019

BUY
$121.41 - $150.02 $1.81 Million - $2.24 Million
14,936 Added 3.73%
415,589 $58.9 Million
Q2 2019

Aug 09, 2019

BUY
$111.27 - $125.15 $7,566 - $8,510
68 Added 0.02%
400,653 $50.1 Million
Q1 2019

May 14, 2019

BUY
$94.53 - $110.2 $2.81 Million - $3.27 Million
29,679 Added 8.0%
400,585 $44.1 Million
Q4 2018

Feb 14, 2019

BUY
$93.0 - $123.98 $709,683 - $946,091
7,631 Added 2.1%
370,906 $36.4 Million
Q3 2018

Nov 13, 2018

BUY
$98.01 - $123.47 $1.73 Million - $2.18 Million
17,642 Added 5.1%
363,275 $44.9 Million
Q2 2018

Aug 08, 2018

BUY
$83.32 - $101.88 $1.97 Million - $2.41 Million
23,700 Added 7.36%
345,633 $34.3 Million
Q1 2018

May 07, 2018

BUY
$85.56 - $102.4 $1.62 Million - $1.94 Million
18,960 Added 6.26%
321,933 $28.4 Million
Q4 2017

Jan 17, 2018

BUY
$91.65 - $101.65 $1.13 Million - $1.26 Million
12,352 Added 4.25%
302,973 $29.9 Million
Q3 2017

Nov 13, 2017

BUY
$84.54 - $96.75 $24.6 Million - $28.1 Million
290,621
290,621 $28 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.